Publications by authors named "Maud Janvier"

Claim this Profile
A
ABVD or BEACOPP along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial.
Christophe Fermé, José Thomas, Pauline Brice, Olivier Casasnovas, Andrej Vranovsky, Maud Janvier

Eur J Cancer· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platine and cytarabine-based salvage treatment for primary central nervous system lymphoma.
Monica Sierra del Rio, Sylvain Choquet, Khé Hoang-Xuan, Sylvie Glaisner, Emmanuelle Fourme, Maud Janvier

J Neurooncol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.
Christian Récher, Bertrand Coiffier, Corinne Haioun, Thierry Jo Molina, Christophe Fermé, Maud Janvier

Lancet· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.
Olivier Fitoussi, Karim Belhadj, Nicolas Mounier, Marie Parrens, Hervé Tilly, Maud Janvier

Haematologica· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.
Frédéric Peyrade, Fabrice Jardin, Catherine Thieblemont, Antoine Thyss, Jean-François Emile, Maud Janvier

Lancet Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deterioration of quality of life of high-risk breast cancer patients treated with high-dose chemotherapy: the PEGASE 01 Quality of Life Study.
Patricia Marino, Henri Roché, Pierre Biron, Maud Janvier, Dominique Spaeth

Value Health· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.
Carole Soussain, Khê Hoang-Xuan, Luc Taillandier, Emmanuelle Fourme, Sylvain Choquet, Maud Janvier

J Clin Oncol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe.
Jean-Paul Fermand, Sandrine Katsahian, Marine Divine, Veronique Leblond, Francois Dreyfus, Maud Janvier

J Clin Oncol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Hodgkin's lymphoma of the breast: a report of 19 cases and a review of the literature.
Stéphan Vignot, Véronique Ledoussal, Philippe Nodiot, Alain Bourguignat, Maud Janvier

Clin Lymphoma· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol.
Jean-Pierre Lotz, Hervé Curé, Maud Janvier, Bernard Asselain, François Morvan

Eur J Cancer· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study.
Sylvie Castaigne, Sylvie Chevret, Eric Archimbaud, Pierre Fenaux, Dominique Bordessoule, Maud Janvier

Blood· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can sequential administration minimise the cost of high dose chemotherapy? An economic assessment in inflammatory breast cancer.
Patricia Marino, Anne-Gaelle Le Corroller, Thao Palangié, Maud Janvier, Michel Fabbro

Pharmacoeconomics· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis